KCT0000256已完成未知
A sequence-randomized, open-label, single dose, crossover study to evaluate pharmacokinetics and safety after oral administration of Plavix® (75mg) and Astrix® (100mg) in free combination and fixed-dose combination as HCP0911 in healthy male volunteers
Hanmi Pharm0 个研究点目标入组 64 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 55(Year)（—）
- 性别
- Male
入选标准
- •Age between 20 and 55
- •Signed informed consent
排除标准
- •Has a history of hypersensitivity to IP ingredients
- •Hypotension or hypertension
- •Has a history of acute infection within 14days of screening
研究者
相似试验
已完成
不适用
Relative bioavailability study of fixed dose combination tablet formulation of GSK587323 (16mg candesartan cilexetil/12.5mg hydrochlorothiazide) under fasting conditionsCTRI/2014/04/004526GlaxoSmithKline Research and Development Limited16
已完成
不适用
Relative bioavailability study of an 16 mg test formulation tablet of candesartan cilexetil (GW615775) under fasting conditionsCTRI/2014/01/004348GlaxoSmithKline Research and Development Limited16
已完成
不适用
Relative bioavailability study of an 8 mg test formulation tablet of candesartan cilexetil (GW615775) under fasting conditionsCTRI/2014/01/004349GlaxoSmithKline Research and Development Limited16
招募中
不适用
The pharmacokinetic characteristics and safety of Rap18001 in postmenopausal femaleDiseases of the musculo-skeletal system and connective tissueKCT0004153Chonbuk National University Hospital6
尚未招募
1 期
Bioequivalence Study of Donepezil HCl 10 mg Orodispersible Tablets in Healthy Thai VolunteersHealthy volunteerDonepezil, Bioequivalence Study, Healthy Thai VolunteerTCTR20230628002International Bio Service Co., Ltd.34